Chemclin Diagnostics Co., Ltd. (SHA:688468)
China · Delayed Price · Currency is CNY 6.61
-0.08 (-1.20%)
Oct 8, 2026, 2:04 PM CST
Chemclin Diagnostics Market Cap
Chemclin Diagnostics has a market cap or net worth of 2.61 billion as of October 7, 2026. That makes Chemclin Diagnostics the world's 16,637th most valuable company and 4,583rd in China. Its market cap has decreased by 14.38% in one year.
Market Cap
2.61B
Enterprise Value
2.32B
Revenue
322.53M
Global Rank
Country Rank
#4,583 China
PE Ratio
74.43
ChartMarket Cap Chart
Since April 9, 2021, Chemclin Diagnostics's market cap has decreased from 10.00B to 2.61B, a decrease of -73.92%. That is a compound annual growth rate of -21.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 2.61B | -9.95% |
| Dec 31, 2025 | 2.90B | 7.15% |
| Dec 31, 2024 | 2.70B | -37.53% |
| Dec 29, 2023 | 4.33B | 13.94% |
| Dec 30, 2022 | 3.80B | -47.15% |
| Dec 31, 2021 | 7.19B | -28.15% |
| Apr 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Strong Biotechnologies,Inc. | 6.98B |
| Shanghai Runda Medical Technology | 6.03B |
| Maccura Biotechnology Co.Ltd | 5.76B |
| Cowealth Medical China | 5.52B |
| Shanghai Labway Clinical Laboratory | 4.79B |
| Guangdong Hybribio Biotech | 3.97B |
| Medicalsystem Biotechnology | 3.94B |
| Berry Genomics Co.,Ltd | 3.84B |